Medical journal refuses to retract vaccine study as demanded by US health secretary
HQ Team August 14, 2025: The Annals of Internal Medicine has refused to retract a recent study that refuted any connection between aluminum
Health
Medical
Uncategorized
ADHD medication linked to lower risk of suicidal behaviour, study finds
August 14, 2025: A new study conducted by researchers at the University of Southampton in the UK and the Karolinska Institute in Sweden
Uncategorized
Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor
HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion
Health
Research
Researchers identify natural alternative to Ozempic: Promising weight loss option
HQ Team August 12, 2025: Researchers from Jiangnan University in China have discovered a potential natural alternative to Ozempic, a popular GLP-1 receptor
Drugs
Health
New pancreatic cancer vaccine shows promise in preventing recurrence in trial-1
HQ Team August 12, 2025: A new study published in the journal Nature Medicine has shown promising results for an experimental vaccine, ELI-002
Climate
Research
Lightning kills 320 million trees annually, climate change will escalate toll further
HQ Team August 12, 2025: A study published in the journal Global Change Biology has revealed that lightning kills approximately 320 million trees
Health
FDA approves VIZZ eye drops: A new option for presbyopia
HQ Team August 11, 2025: The US Food and Drug Administration (FDA) has granted approval to VIZZ (aceclidine ophthalmic solution 1.44%), an innovative
Drugs
Research
Novartis’s Ianalumab has positive Phase III results for Sjögren’s Syndrome
HQ Team August. 11, 2025: Novartis AG announced positive Phase III trial results for its experimental autoimmune drug, Ianalumab (VAY736), in treating Sjögren’s
Health
Pharma
Research
UK researchers unravel 8 gene variants in chronic fatigue syndrome
About 67 million people globally living with chronic fatigue syndrome have different genes compared to their healthy counterparts, initial findings from the world's
Drugs
Health
Pharma
Jazz Pharma’s oral drug for a type of brain tumour gets US approval
Jazz Pharmaceuticals Plc’s treatment for a rare and aggressive brain tumour that affects children and adults got approval from the US regulator.